(Circulation. 2001;103:462.)
© 2001 American Heart Association, Inc.
Current Perspective |
Sino-MONICA Project
A Collaborative Study on Trends and Determinants in Cardiovascular Diseases in China, Part I: Morbidity and Mortality Monitoring
From the Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Correspondence to Department of Epidemiology, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Andingmenwai, Beijing 100029, China. E-mail wuzhaosu{at}263.net
Background—The Sino-MONICA project is a 7-year study monitoring trends and determinants of cardiovascular disease (CVD) in geographically defined populations in different parts of China.
Methods and Results—The study is a community-based prospective disease surveillance that uses the methodology and criteria of the World Health Organization’s Monitoring Trends and Determinants in Cardiovascular Disease (WHO MONICA) project, with slight modifications for local use. After a pilot study of 2 years (1985 through 1986), data collection started formally on January 1, 1987, and ended on December 31, 1993. The main results were as follows. By international standards, both the incidence and mortality rate of coronary heart disease in Chinese populations were low. The highest incidence was 108.7 of 100 000 (1987 to 1989), and the lowest was 3.3 of 100 000 for men 35 to 64 years of age, a 33-fold difference. Both the incidence and mortality rate of cerebrovascular disease were high. The highest incidence was 553.3 of 100 000 (1987 to 1989), and the lowest was 33.0 of 100 000 for men 35 to 64 years of age, a 17-fold difference. There were significant geographic variations in both CVD incidence and mortality rate, with higher rates in the north and lower rates in the south. During 1987 to 1993, increasing trends were found in CVD rates in some populations, whereas decreasing trends were found in others. The trends were not significant statistically in most cases.
Conclusions—Monitoring CVD with international standardized methods in China is feasible and urgently needed in view of the rapid socioeconomic development and transition of disease patterns taking place in China. The results are of significance in combating CVD both at home and abroad.
Key Words: cardiovascular diseases • risk factors • mortality • trials
This article has been cited by other articles:
 |
|
 |
|
  D. Zhao, J. Liu, W. Wang, Z. Zeng, J. Cheng, J. Liu, J. Sun, and Z. Wu Epidemiological Transition of Stroke in China: Twenty-One-Year Observational Study From the Sino-MONICA-Beijing Project Stroke, June 1, 2008; 39(6): 1668 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mahabir, C. C Abnet, Y.-L. Qiao, L. D Ratnasinghe, S. M Dawsey, Z.-W. Dong, P. R Taylor, and S. D Mark A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China J. Epidemiol. Community Health, August 1, 2007; 61(8): 737 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. He, B. Jiang, J. Wang, K. Feng, Q. Chang, S. Zhu, L. Fan, X. Li, and F. B. Hu BMI Versus the Metabolic Syndrome in Relation to Cardiovascular Risk in Elderly Chinese Individuals Diabetes Care, August 1, 2007; 30(8): 2128 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, W.-Y. So, A. P.S. Kong, C.-S. Ho, C. W.K. Lam, R. J. Stevens, R. R. Lyu, D. D. Yin, C. S. Cockram, P. C.Y. Tong, et al. Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes: The Hong Kong Diabetes Registry Diabetes Care, January 1, 2007; 30(1): 65 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, L. Zuo, F. Wang, M. Wang, S. Wang, J. Lv, L. Liu, and H. Wang Cardiovascular Disease in Early Stages of Chronic Kidney Disease in a Chinese Population J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2617 - 2621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, S. M. Grundy, W. Wang, S. C. Smith Jr, G. L. Vega, Z. Wu, Z. Zeng, W. Wang, and D. Zhao Ethnic-Specific Criteria for the Metabolic Syndrome: Evidence from China. Diabetes Care, June 1, 2006; 29(6): 1414 - 1416. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. He, B. Jiang, J. Wang, K. Feng, Q. Chang, L. Fan, X. Li, and F. B. Hu Prevalence of the Metabolic Syndrome and its Relation to Cardiovascular Disease in an Elderly Chinese Population J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1588 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Jiang, W.-z. Wang, H. Chen, Z. Hong, Q.-d. Yang, S.-p. Wu, X.-l. Du, and Q.-j. Bao Incidence and Trends of Stroke and Its Subtypes in China: Results From Three Large Cities Stroke, January 1, 2006; 37(1): 63 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Woo, T. W. Yip, S. Kwong, P. Chook, and L. C. Kum Commentary: Smoking and atherosclerotic diseases in Asia--the implication in global atherosclerosis prevention Int. J. Epidemiol., October 1, 2005; 34(5): 1045 - 1046. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Muntner, D. Gu, R. P. Wildman, J. Chen, W. Qan, P. K. Whelton, and J. He Prevalence of Physical Activity Among Chinese Adults: Results From the International Collaborative Study of Cardiovascular Disease in Asia Am J Public Health, September 1, 2005; 95(9): 1631 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gu, A. Gupta, P. Muntner, S. Hu, X. Duan, J. Chen, R. F. Reynolds, P. K. Whelton, and J. He Prevalence of Cardiovascular Disease Risk Factor Clustering Among the Adult Population of China: Results From the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia) Circulation, August 2, 2005; 112(5): 658 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Critchley, J. Liu, D. Zhao, W. Wei, and S. Capewell Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999 Circulation, September 7, 2004; 110(10): 1236 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. He, D. Gu, K. Reynolds, X. Wu, P. Muntner, J. Zhao, J. Chen, D. Liu, J. Mo, P. K. Whelton, et al. Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China Circulation, July 27, 2004; 110(4): 405 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, Y. Hong, R. B. D'Agostino Sr, Z. Wu, W. Wang, J. Sun, P. W. F. Wilson, W. B. Kannel, and D. Zhao Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared With the Chinese Multi-provincial Cohort Study JAMA, June 2, 2004; 291(21): 2591 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-F. Zhang, J. Attia, C. D'Este, and X.-H. Yu Prevalence and Magnitude of Classical Risk Factors for Stroke in a Cohort of 5092 Chinese Steelworkers Over 13.5 Years of Follow-up Stroke, May 1, 2004; 35(5): 1052 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-F. Zhang, J. Yang, Z. Hong, G.-G. Yuan, B.-F. Zhou, L.-C. Zhao, Y.-N. Huang, J. Chen, and Y.-F. Wu Proportion of Different Subtypes of Stroke in China Stroke, September 1, 2003; 34(9): 2091 - 2096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Truelsen, M. Mahonen, H. Tolonen, K. Asplund, R. Bonita, and D. Vanuzzo Trends in Stroke and Coronary Heart Disease in the WHO MONICA Project Stroke, June 1, 2003; 34(6): 1346 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gu, K. Reynolds, X. Wu, J. Chen, X. Duan, P. Muntner, G. Huang, R. F. Reynolds, S. Su, P. K. Whelton, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China Hypertension, December 1, 2002; 40(6): 920 - 927. [Abstract] [Full Text] [PDF]
|
|